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LETTERS
Coronavirus HKU1 
in Children, Brazil, 
1995
To the Editor: Coronavirus 
HKU1 is a newly identiﬁ  ed  human 
coronavirus (HCoV) that was reported 
ﬁ  rst in 2005 in Hong Kong Special 
Administrative Region, People’s 
Republic of China; later in Australia, 
Europe, and the United States, and 
more recently in Brazil, demonstrating 
a global distribution (1–3). We 
examined the circulation of HCoV 
in Brazil and the possible presence 
of the new HCoV types, with special 
attention to coronavirus HKU1, in 
samples collected back to 1995, tested 
by using universal coronavirus PCR.
The epidemiologic proﬁ  le 
of HCoV was retrospectively 
investigated with samples collected 
during March–December 1995 in a 
pediatric ward of University Hospital, 
São Paulo University, São Paulo, 
Brazil. The Ethics Committee on 
Research Involving Human Subjects 
of the Institute of Biomedical Sciences, 
University of São Paulo, approved the 
study. Samples of nasopharyngeal 
aspirates were collected from 169 
hospitalized children, ages 7 days–15 
years, of whom 104 had respiratory 
symptoms, 23 had enteric disease, 
and 3 had both (4). The mean age of 
the study population was 19.6 months 
(median 7 months). Viral nucleic acid 
was extracted from specimens by using 
Trizol (Invitrogen, Carlsbad, CA, 
USA) following the manufacturer’s 
instructions. Total RNA was then 
submitted to reverse transcription PCR 
with a High-Capacity cDNA Archive 
Kit (Applied Biosystems, Foster City, 
CA, USA) by using random primers 
according to the manufacturer’s 
instructions. The cDNA obtained was 
screened with primers able to amplify 
a 220-bp product in the conserved 
polymerase region of all known 
HCoVs (5) and other coronaviruses 
(e.g., bovine coronavirus). We used 
cDNA obtained from cultured human 
rectal tumor cell line HRT-18G cells 
inoculated with bovine coronavirus 
strain Kakegawa as positive controls 
for PCR.
In an attempt to improve the 
sensitivity of HKU1 detection, we 
analyzed samples with negative 
results by PCR with a nested PCR 
speciﬁ   c for coronavirus HKU1. 
This nested assay was designed on 
an alignment of our HKU1-positive 
sample sequence (BRA169) and 
different HKU1 genotype sequences 
deposited in GenBank. Primers 
Fn-HKU1 (forward 5′-CGTGCYA
TGCCAAATATTTTGCG-3′,  HKU1-
NC_006577, nt 15433–15454) and 
Rn-HKU1 (reverse 5′-TAGCAACC
GCCACACATAAC-3′, HKU1-NC_
006577, nt 15562–15581) produced an 
amplicon of 149 bp. The nested PCR 
was run in a 50-μL reaction comprising 
10 μL of PCR product, 1.5 units of 
DNA Polymerase (Biotools, Madrid, 
Spain), 1 μmol/L of each primer, 
200 μmol/L of each dNTP (Applied 
Biosystems), 2 mmol/L MgCl2, and 1× 
buffer. PCR mixtures were heated to 
95°C for 5 min, followed by 35 cycles 
of 1 min at 95°C, 30 s at 62°C, and 
40 s at 72°C, followed by a ﬁ  nal 10 
min at 72°C. Clinical samples positive 
for HKU1 were used as positive 
controls in the HKU1 nested PCR. 
All fragments obtained from PCR and 
nested PCR were analyzed in a 2% (wt/
vol) agarose gel by electrophoresis, 
stained with 0.5 μg/mL of ethidium 
bromide, and subsequently sequenced 
to conﬁ   rm the type of coronavirus. 
Nucleotide sequencing reactions were 
performed on both amplicon strands 
by using an ABI PRISM Big Dye 
Cycle Sequencing Kit with the ABI 
PRISM 3100 automatic sequencer 
(Applied Biosystems).
Six (3.6%) samples tested 
positive for HCoV-HKU1: 2 samples 
by PCR and 4 by nested PCR. HCoV 
types 229E, OC43, and NL63 were 
not detected in any sample by PCR. 
Samples positive for HCoV were 
associated with pertussis, pneumonia, 
bronchiolitis, and diarrhea (Table).
In a recent review, an analysis of 
18 studies indicated that the median 
(range) incidence of HCoV-HKU1 
was 0.9% (0%–4.4%) (2), which is 
similar to the detection rate in our 
study. To our knowledge, the only 
study that has screened for HKU1 in 
Brazil found that 0.48% of children 
were positive for HKU1 (3), which is 
lower than our results. 
Although we did not detect 
other HCoV types, all HCoV types 
were detected previously in Brazil in 
samples collected during 2006–2008 
(3,6). The absence of detection of 
229E, OC43, and NL63 HCoV might 
have resulted from the seasonality and 
natural viral year cycle or from the 
characteristics of the children studied 
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Table. Epidemiologic and laboratory data of children with coronavirus infection, Brazil, 1995* 
Specimen no.: HCoV 
strain by pol analyses Age/sex
Sample
collection date Clinical diagnosis  Co-infections
Detection method, fragment 
sequenced
09: HKU1A  3 mo/F  Mar  Pertussis ND  Nested PCR, 143 bp 
37: HKU1A  2 mo/M  Apr Bronchiolitis plus 
bronchopneumonia 
RSV Nested PCR, 143 bp 
90: HKU1B  4 mo/M  Jul Upper respiratory infection  ND  Nested PCR, 143 bp 
99: HKU1 B  9 y/M  Jul Pleural effusion pneumonia  ND  Nested PCR, 143 bp 
104: HKU1 A  2 mo/F  Jul Pertussis ND  Pancoronavirus PCR, 143 bp 
169: HKU1B  3 y/F  Nov Fever, diarrhea  Worms  Pancoronavirus PCR, 173 bp 
*HCoV, human coronavirus; ND, not detected; RSV, respiratory syncytial virus. LETTERS
because we included samples from 




genetic analysis of amplicons from 
PCR and nested PCR indicated that 
samples were positive for HKU1 
genotype B (samples BRA169, 
BRA90, and BRA99) or HKU1 
genotype A (samples BRA09, BRA37, 
and BRA104). The sequences obtained 
in this study have been deposited 
in GenBank under accession nos. 
FJ931534.1 (BRA169), GU904424 
(BRA37), GU904427 (BRA104), 
GU904423 (BRA09), GU904425 
(BRA90), and GU904426 (BRA99).
This may be the oldest collection 
of human samples in which HKU1 
has been detected. To our knowledge, 
the oldest previous sample positive 
for HCoV-HKU1 was detected in 
children in Finland during 1996–1998, 
without an exact date speciﬁ  ed  (7). 
Retrospective studies also have been 
conducted in the United States and 
Greece that showed the HKU1 virus 
in different countries in Europe and 
North America before its discovery 
(8,9). We have conﬁ  rmed  the 
circulation of HKU1 coronaviruses in 
children in Brazil in 1995.
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To the Editor:  Mycoplasma 
genitalium is now recognized as 
a serious pathogen in sexually 
transmitted infections (1,2). 
Azithromycin regimens have been 
commonly used for treatment of M. 
genitalium infections (3). However, 
failure of azithromycin treatment 
has been reported in cases of M. 
genitalium–positive nongonococcal 
urethritis (NGU) (4,5), and macrolide-
resistant strains of M. genitalium 
have been isolated from case-patients 
in Australia, Sweden, and Norway 
for whom azithromycin treatment 
has failed (4,5). In these strains, 
mutations in the 23S rRNA gene were 
associated with macrolide resistance, 
and mutations in ribosomal protein 
genes L4 and L22 were also found 
(5). Surveillance for antimicrobial 
resistance of M. genitalium is 
essential to identify antimicrobial 
resistant strains and to then determine 
appropriate treatment. Coculture of 
patient specimens with Vero cells 
has improved the primary isolation 
rate of M. genitalium from clinical 
specimens and offered some current 
clinical strains for antimicrobial drug 
susceptibility testing (6). To determine 
their antimicrobial susceptibilities, 
a molecular real-time PCR method 
has been developed (7,8). However, 
isolating M. genitalium from clinical 
specimens and antimicrobial drug 
susceptibility testing of clinical 
isolates remain labor-intensive, 
time-consuming tasks. In addition, 
no methods are available to directly 
determine antimicrobial drug 
susceptibilities of M. genitalium 
in clinical specimens. To monitor 
macrolide susceptibilities in clinical 
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